Developing World Health
Developing World Health (DWH) is primarily focused on developing new treatments and disease prevention measures for neglected tropical diseases (NTDs).
DWH has two main strategic aims:
- The development of new treatments for NTDs such as leishmaniasis , African trypanosomiasis, Chagas Disease and Dengue Fever.
- Fundraising and advocacy to help implementation of NTD mass drug administration to treat the 7 most common NTDs in Sub Saharan Africa (SSA).
DWH is working in partnership with the Schistosomiasis Control Initiative (SCI), part of Imperial College of London, which has been at the forefront of NTD control programmes in sub- Saharan Africa for several years. Together with the SCI, DWH have established a joint venture to implement a National advocacy and fundraising campaign called the 50p ‘Life Change’ Appeal. For every 50pence raised DWH and SCI can together treat a child for an entire year against the 7 most common and devastating NTDs. The other aims of the Appeal are to increase awareness of NTDs, generate the necessary momentum, political goodwill and necessary funds to help eliminate these disabling, disfiguring, and deadly diseases.